Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;44(6):e2100256.
doi: 10.1002/bies.202100256. Epub 2022 Mar 31.

Non-coding RNAs in Kawasaki disease: Molecular mechanisms and clinical implications

Affiliations
Review

Non-coding RNAs in Kawasaki disease: Molecular mechanisms and clinical implications

Fuqing Yang et al. Bioessays. 2022 Jun.

Abstract

Kawasaki disease (KD) is an acute self-limiting vasculitis with coronary complications, usually occurring in children. The incidence of KD in children is increasing year by year, mainly in East Asian countries, but relatively stably in Europe and America. Although studies on KD have been reported, the pathogenesis of KD is unknown. With the development of high-throughput sequencing technology, growing number of regulatory noncoding RNAs (ncRNAs) including microRNA (miRNA), long noncoding RNA (lncRNA), and circular RNA (circRNA) have been identified to involved in KD. However, the role of ncRNAs in KD has not been comprehensively elucidated. Therefore, it is significative to study the regulatory role of ncRNA in KD, which might help to uncover new and effective therapeutic strategies for KD. In this review, we summarize recent studies on ncRNA in KD from the perspectives of immune disorders, inflammatory disorders, and endothelial dysfunction, and highlight the potential of ncRNAs as therapeutic targets for KD.

Keywords: Kawasaki disease; circRNA; endothelial dysfunction; immune dysfunction; inflammatory disorder; lncRNA; miRNA.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Newburger, J. W., Takahashi, M., & Burns, J. C. (2016). Kawasaki Disease. Journal of the American College of Cardiology, 67(14), 1738-1749.
    1. Singh, S., Vignesh, P., & Burgner, D. (2015). The epidemiology of Kawasaki disease: A global update. Archives of Disease in Childhood, 100(11), 1084-1088.
    1. Gordon, J. B., Daniels, L. B., Kahn, A. M., Jimenez-Fernandez, S., Vejar, M., Numano, F., & Burns, J. C. (2016). The spectrum of cardiovascular lesions requiring intervention in adults after Kawasaki disease. JACC: Cardiovascular Interventions, 9(7), 687-696.
    1. Uehara, R., & Belay, E. D. (2012). Epidemiology of Kawasaki disease in Asia, Europe, and the United States. Journal of Epidemiology, 22(2), 79-85.
    1. Miura, M., Kobayashi, T., Kaneko, T., Ayusawa, M., Fukazawa, R., Fukushima, N., Fuse, S., Hamaoka, K., Hirono, K., Kato, T., Mitani, Y., Sato, S., Shimoyama, S., Shiono, J., Suda, K., Suzuki, H., Maeda, J., Waki, K., Kato, H., … Yamamura, K. (2018). Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatrics, 172(5), e180030.

Publication types

LinkOut - more resources